共 56 条
[1]
Miller R.W., Young Jr. J.L., Novakovic B., Childhood cancer, Cancer, 75, pp. 395-405, (1995)
[2]
Brodeur G.M., Castleberry R.P., Neuroblastoma, Principles and Practice of Pediatric Oncology, 3rd Edn., pp. 761-797, (1996)
[3]
Kushner B.H., Gilbert F., Helson L., Familial neuroblastoma: Case reports, literature review, and etiologic considerations, Cancer, 57, pp. 1887-1893, (1986)
[4]
Beckwith J.B., Perrin E.V., In situ neuroblastomas: A contribution to the natural history of neural crest tumors, Am J Pathol, 43, pp. 1089-1100, (1963)
[5]
Hasegawa R., Tatematsu M., Imaida K., Et al., Neuroblastoma in situ, Acta Pathol Jpn, 32, pp. 537-546, (1982)
[6]
Brodeur G.M., Pritchard J., Berthold F., Et al., Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment, J Clin Oncol, 11, pp. 1466-1477, (1993)
[7]
Itoh T., Ohmori K., Biosynthesis and storage of catecholamines in pheochromocytoma and neuroblastoma cells, J Lab Clin Med, 81, pp. 887-896, (1973)
[8]
Laug W.E., Siegel S.E., Shaw K.N.F., Et al., Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma, Pediatrics, 62, pp. 77-83, (1978)
[9]
LaBrosse E.H., Com-Nougue C., Zucker J.M., Et al., Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors, Cancer Res, 40, pp. 1995-2001, (1980)
[10]
Graham-Pole J., Salmi T., Anton A.H., Et al., Tumor and urine cathecholamines (CATs) in neurogenic tumors. Correlations with other prognostic factors and survival, Cancer, 51, pp. 834-839, (1983)